Don’t miss the latest developments in business and finance.

Over 1 mn Covid cases reported in US amid rapid spread of Omicron variant

The US on Monday reported over 1 million COVID-19 cases amid rapid spread of the Omicron variant.

Covid, New York, Omicron
People queue up for a Covid test at a popup testing site as the Omicron variant continues to spread across New York City
ANI
2 min read Last Updated : Jan 04 2022 | 10:23 AM IST

The US on Monday reported over 1 million COVID-19 cases amid rapid spread of the Omicron variant.

The US health authorities registered more than three times as many new cases as in any previous wave of the coronavirus, over 1 million reported on Monday alone, reported USA TODAY.

A substantial increase in coronavirus infections was expected when this week's numbers came out, but nothing like this. About 1 of every 100 Americans will have been reported as a positive case in just the last week, according to data from Johns Hopkins University.

On Tuesday, President Joe Biden and Vice President Kamala Harris planned to meet with the White House coronavirus response team to discuss a course of action as omicron becomes ubiquitous, reported USA TODAY.

By 7:30 pm ET Monday, Johns Hopkins University data showed about 1,042,000 more cases than the day before, and it wasn't immediately clear that all states had reported in. That count clearly includes hefty numbers of backlogged cases.

About one-fifth of states reported infections Saturday and one-third Sunday. Still, the previous single-day record was about 591,000 cases, set Thursday, reported USA TODAY.

Also Read

The preliminary total for Monday could drive the country to a weekly average of close to 450,000 cases per day. The previous highest total for a whole week, 1.76 million, figures to be not only surpassed but possibly doubled.

The US has recorded more than 55 million confirmed COVID-19 cases, or one for every six people in the country -- and more than 826,000 deaths, according to Johns Hopkins University data.

Meanwhile, the Food and Drug Administration on Monday expanded the emergency use authorization of a booster dose of the Pfizer-BioNTech coronavirus vaccine to include youths 12 to 15.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

More From This Section

Topics :CoronavirusOmicronUnited StatesCoronavirus TestsCoronavirus Vaccine

First Published: Jan 04 2022 | 10:23 AM IST

Next Story